BARDA

Funding rounds backed by BARDA.

Export CSV
Funding disclosed in full
$60M
Median round
$60M
Rounds in calculation
1
Funding rounds with company descriptions, amounts, stages and announcement dates
CompanyRoundMarketInvestorsAnnouncedDetails
Vedanta Biosciences

Develops microbiome-based oral therapies for prevention of recurrent C. difficile infection

$60MGrowthBiotechUnited States
3 participantsAMR Action FundBARDABNP Paribas Asset Management Alts